Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

iwNHL 2014 | 12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: Day 1 meeting highlights

John Gribben, Myron Czuczman, Randy Gascoyne and Wyndham Wilson • 5 Sep 2014
iwNHL 2014
General Non-Hodgkin Lymphoma

Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada), Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA) and Dr Myron Czuczman (Roswell Park Cancer Institute, Buffalo, USA) about the highlights from day one of the 12th iwNHL.

More from John Gribben

2:42
Investigating the treatment preferences of physicians in R/R follicular lymphoma
John Gribben • 9 Dec 2023
1:20
Axi-cel in R/R FL: an updated comparison of ZUMA-5 and the SCHOLAR-5 external control cohort
John Gribben • 9 Dec 2023
1:04
The future of CLL therapy
John Gribben • 9 Dec 2023
Novel therapies in NHL: antibody-drug conjugates
Andrew Davies et al. • 17 Oct 2023

More from Myron Czuczman

10:51
Update of targeted or chemotherapy-free therapies in lymphoma
John Gribben et al. • 5 Sep 2014
23:19
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: Day 2 meeting highlights
Anton Hagenbeek et al. • 9 Apr 2015

More from Randy Gascoyne

2:20
Lymphoma Microenvironment: biology and therapy (part 2/3)
John Gribben et al. • 5 Sep 2014
5:59
Lymphoma microenvironment: biology and therapy (part 1/3)
John Gribben et al. • 5 Sep 2014
7:27
Lymphoma microenvironment: biology and therapy (part 3/3)
John Gribben et al. • 5 Sep 2014
9:18
iwNHL 2015 roundtable: Using B-cell biology to inform therapy
Kieron Dunleavy et al. • 3 Oct 2015

More from Wyndham Wilson

4:17
Ibrutinib in DLBCL: revelations from further analysis of PHOENIX
Wyndham Wilson • 2 Jul 2019
1:12
Liquid biopsy to measure MRD
Wyndham Wilson • 2 Jul 2019
2:30
ViPOR regimen for R/R B-cell lymphoma
Wyndham Wilson • 2 Jul 2019
2:49
Liquid biopsy making strides forward in NHL: detection of ctDNA and mutations
Wyndham Wilson • 2 Jul 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals